Conor McNamara
Stock Analyst at RBC Capital
(1.00)
# 3,807
Out of 4,966 analysts
136
Total ratings
27%
Success rate
-15.93%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $2.38 | +110.08% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $167.88 | +51.89% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.64 | +82.93% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $46.95 | -2.02% | 1 | Aug 7, 2025 | |
| TECH Bio-Techne | Maintains: Sector Perform | $63 → $61 | $54.33 | +12.28% | 10 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $66.62 | +30.59% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $13.21 | +28.69% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $99.17 | +27.05% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $293.67 | +39.27% | 12 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $297.35 | +37.55% | 12 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $122.17 | +66.98% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $489.74 | +30.07% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $205.29 | +21.78% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $28.00 | +117.86% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.38 | +107.10% | 4 | Aug 7, 2024 |
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $2.38
Upside: +110.08%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $167.88
Upside: +51.89%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.64
Upside: +82.93%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $46.95
Upside: -2.02%
Bio-Techne
Aug 7, 2025
Maintains: Sector Perform
Price Target: $63 → $61
Current: $54.33
Upside: +12.28%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $66.62
Upside: +30.59%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $13.21
Upside: +28.69%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $99.17
Upside: +27.05%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $293.67
Upside: +39.27%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $297.35
Upside: +37.55%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $122.17
Upside: +66.98%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $489.74
Upside: +30.07%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $205.29
Upside: +21.78%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $28.00
Upside: +117.86%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.38
Upside: +107.10%